US President-elect Donald Trump has said he will consider an "amended" version of Barack Obama's signature health care law—a sign of a shift in position after repeatedly vowing on the campaign trail that he would repeal ...
Nov 11, 2016
0
7
Pfizer will pay about $14 billion in cash for the cancer drug company Medivation, a deal that will add the pricey late-stage prostate cancer treatment Xtandi to its oncology portfolio.
Aug 22, 2016
0
1
Shareholders of the drugmaker Perrigo shut the door on a $26-billion hostile takeover bid from Mylan.
Nov 13, 2015
0
3
Pharmaceutical giant Pfizer recently approached Botox-maker Allergan over what would be the biggest takeover deal this year, The Wall Street Journal said Wednesday.
Oct 29, 2015
0
11
Aetna aims to spend about $35 billion to buy rival Humana and become the latest health insurer bulking up on government business as the industry adjusts to the federal health care overhaul.
Jul 3, 2015
0
6
Despite questions about four challengers' legal right to bring their lawsuit, the Supreme Court probably will not be deterred from deciding whether millions of people covered by the health care overhaul are eligible for the ...
Feb 14, 2015
1
4
A prominent program that claims to reduce infant and maternal deaths in rural India by encouraging mothers to deliver in private hospitals has been unsuccessful, despite the investment of more than $25 million since 2005, ...
Dec 11, 2013
0
0
US pharmaceutical distributor McKesson on Thursday announced the purchase of German rival Celesio in a deal valued at more than $8 billion.
Oct 24, 2013
0
0
Indian group Sun Pharmaceutical Industries is in talks to buy leading Swedish drugmaker Meda AB in what could result in a $5 billion takeover, the Wall Street Journal reported on Friday.
May 31, 2013
0
0
Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical ...
Apr 25, 2013
0
0
